ESC 365 - Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)

ESC Professional Premium Access

Sacubitril/valsartan for treatment of symptomatic non-obstructive hypertrophic cardiomyopathy: a randomised, controlled, phase II clinical trial (SILICOFCM)

Session: Contemporary management of hypertrophic cardiomyopathy

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor M. Tafelmeier (Regensburg, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Maria Tafelmeier

University Hospital Regensburg, Regensburg (Germany)

0 follower

5 more presentations in this session

Long-term effects of mavacamten treatment in obstructive hypertrophic cardiomyopathy (HCM): updated cumulative analysis of the EXPLORER cohort of MAVA-long-term extension (LTE) study up to 120 weeks

Speaker: Doctor P. Garcia-Pavia (Majadahonda, ES)

Efficacy of cardiac myosin inhibitors for obstructive hypertrophic cardiomyopathy: a systematic review and meta-analysis of randomised controlled trials

Speaker: Ms N. Felix (Cajazeiras, BR)

Long term outcome after septal reduction therapies in patients with hypertrophic cardiomyopathy: insights from the SHaRe registry

Speaker: Doctor N. Maurizi (Lausanne, CH)

Outcomes in patients with hypertrophic cardiomyopathy developing left ventricular systolic dysfunction after septal reduction therapy

Speaker: Miss D. Hiestand (Zurich, CH)

The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation: a systematic review and meta-analysis

Speaker: Miss S. Lyu (Beijing, CN)

Access the full session

Contemporary management of hypertrophic cardiomyopathy

Speakers: Doctor M. Tafelmeier, Doctor P. Garcia-Pavia, Ms N. Felix, Doctor N. Maurizi, Miss D. Hiestand...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources